- SEK125.80m
- SEK123.22m
- SEK32.20m
- 39
- 10
- 56
- 22
Annual balance sheet for Medclair AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PRESS | ARS | ARS | Interim Report | ARS |
Standards: | — | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.972 | 20.2 | 3.89 | 3.2 | 2.58 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.12 | 1.89 | 4.39 | 5.87 | 7.23 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 6.48 | 27.3 | 23.3 | 18 | 19.5 |
Net Property, Plant And Equipment | 0.033 | 0.014 | 4.49 | 5.02 | 6.27 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 45.9 | 64.6 | 63.9 | 58.7 | 60 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.88 | 5.93 | 10.8 | 8.49 | 10.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.47 | 6.82 | 11.2 | 8.49 | 10.9 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 39.4 | 57.7 | 52.7 | 50.2 | 49 |
Total Liabilities & Shareholders' Equity | 45.9 | 64.6 | 63.9 | 58.7 | 60 |
Total Common Shares Outstanding |